相似文献
1
Treatment of hantavirus pulmonary syndrome.
Antiviral Res. 2008 Apr;78(1):162-9. doi: 10.1016/j.antiviral.2007.10.012. Epub 2007 Nov 21.
2
A lethal disease model for hantavirus pulmonary syndrome.
Virology. 2001 Oct 10;289(1):6-14. doi: 10.1006/viro.2001.1133.
3
Hemorrhagic Fever with Renal Syndrome in the New, and Hantavirus Pulmonary Syndrome in the Old World: paradi(se)gm lost or regained?
Virus Res. 2014 Jul 17;187:55-8. doi: 10.1016/j.virusres.2013.12.036. Epub 2014 Jan 17.
4
Progress on the Prevention and Treatment of Hantavirus Disease.
Viruses. 2019 Jul 4;11(7):610. doi: 10.3390/v11070610.
5
Hantavirus pulmonary syndrome.
Virus Res. 2011 Dec;162(1-2):138-47. doi: 10.1016/j.virusres.2011.09.017. Epub 2011 Sep 17.
6
Hantavirus pulmonary syndrome: epidemiology, prevention, and case presentation of a new viral strain.
Nurse Pract. 1996 Jun;21(6):89-90, 93, 96 passim.
7
Hantavirus pulmonary syndrome: a concise clinical review.
South Med J. 2009 Jun;102(6):620-5. doi: 10.1097/SMJ.0b013e3181a4eeda.
8
Hantaviruses. a short review.
Arch Pathol Lab Med. 2003 Jan;127(1):30-5. doi: 10.5858/2003-127-30-.
9
[Emerging viral zoonoses: hantavirus infections].
Rev Sci Tech. 2004 Aug;23(2):595-611.
10
Hantavirus protein interactions regulate cellular functions and signaling responses.
Expert Rev Anti Infect Ther. 2011 Jan;9(1):33-47. doi: 10.1586/eri.10.157.
引用本文的文献
1
Pathogenicity and virulence of Rodent-Borne Orthohantaviruses.
Virulence. 2025 Dec;16(1):2553784. doi: 10.1080/21505594.2025.2553784. Epub 2025 Sep 4.
2
Sin Nombre Virus and the Emergence of Other Hantaviruses: A Review of the Biology, Ecology, and Disease of a Zoonotic Pathogen.
Biology (Basel). 2023 Nov 9;12(11):1413. doi: 10.3390/biology12111413.
3
Modeling the Immune Response for Pathogenic and Nonpathogenic Infections in Human Lung Microvasculature Endothelial Cells.
Viruses. 2023 Aug 24;15(9):1806. doi: 10.3390/v15091806.
4
Emerging Maripa Hantavirus as a Potential Cause of a Severe Health Threat in French Guiana.
Am J Trop Med Hyg. 2023 Mar 13;108(5):1014-1016. doi: 10.4269/ajtmh.22-0390. Print 2023 May 3.
5
Opportunistic etiological agents causing lung infections: emerging need to transform lung-targeted delivery.
Heliyon. 2022 Dec 26;8(12):e12620. doi: 10.1016/j.heliyon.2022.e12620. eCollection 2022 Dec.
6
The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.
Clin Kidney J. 2022 Jan 29;15(7):1231-1252. doi: 10.1093/ckj/sfac008. eCollection 2022 Jul.
7
Hantavirus Pulmonary Syndrome in a COVID-19 Patient, Argentina, 2020.
Emerg Infect Dis. 2022 Apr;28(4):876-878. doi: 10.3201/eid2804.211837. Epub 2022 Feb 24.
8
Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters.
Emerg Infect Dis. 2021 Oct;27(10):2707-2710. doi: 10.3201/eid2710.210735.
9
Binding of the Andes Virus Nucleocapsid Protein to RhoGDI Induces the Release and Activation of the Permeability Factor RhoA.
J Virol. 2021 Aug 10;95(17):e0039621. doi: 10.1128/JVI.00396-21.
10
Chloroquine, an Anti-Malaria Drug as Effective Prevention for Hantavirus Infections.
Front Cell Infect Microbiol. 2021 Mar 15;11:580532. doi: 10.3389/fcimb.2021.580532. eCollection 2021.
本文引用的文献
1
Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters.
J Virol. 2007 Jul;81(14):7449-62. doi: 10.1128/JVI.00238-07. Epub 2007 May 2.
2
Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in chile.
J Infect Dis. 2007 Jun 1;195(11):1563-71. doi: 10.1086/516786. Epub 2007 Apr 16.
3
Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome.
J Infect Dis. 2007 May 15;195(10):1541-9. doi: 10.1086/513874. Epub 2007 Apr 5.
4
Ribavirin, human convalescent plasma and anti-beta3 integrin antibody inhibit infection by Sin Nombre virus in the deer mouse model.
J Gen Virol. 2007 Feb;88(Pt 2):493-505. doi: 10.1099/vir.0.82459-0.
5
Phylogenetic and geographical relationships of hantavirus strains in eastern and western Paraguay.
Am J Trop Med Hyg. 2006 Dec;75(6):1127-34.
6
Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins.
Vaccine. 2007 Feb 19;25(9):1690-9. doi: 10.1016/j.vaccine.2006.09.082. Epub 2006 Oct 11.
7
Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome.
J Infect Dis. 2006 Nov 15;194(10):1403-9. doi: 10.1086/508494. Epub 2006 Oct 10.
8
Tumor necrosis factor-alpha genetic predisposing factors can influence clinical severity in nephropathia epidemica.
Viral Immunol. 2006 Summer;19(3):558-64. doi: 10.1089/vim.2006.19.558.
9
Incubation period of hantavirus cardiopulmonary syndrome.
Emerg Infect Dis. 2006 Aug;12(8):1271-3. doi: 10.3201/eid1208.051127.
10
Characterization of shock in a hamster model of hantavirus infection.
Virology. 2006;356(1-2):45-9. doi: 10.1016/j.virol.2006.07.044. Epub 2006 Sep 6.
Zotero 插件